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ABSTRACT
Background Osteoarthritis is the leading cause of
disability in older adults. Evidence of effectiveness for
self-management of hand osteoarthritis is lacking.
Methods In this randomised, factorial trial, we
evaluated the effectiveness of joint protection versus no
joint protection, and hand exercise versus no hand
exercise in adults, 50 years of age or older, with hand
osteoarthritis. Following a population survey (n=12 297),
eligible individuals were randomly assigned (1:1:1:1) to:
leaﬂet and advice; joint protection; hand exercise; joint
protection plus hand exercise. Joint protection and hand
exercises were delivered by nine occupational therapists,
over four group sessions. The primary outcome was the
OARSI/OMERACT responder criteria at 6 months.
Outcomes were collected blind to allocation (3, 6,
12 m). Analysis was by intention to treat.
Results Of 257 participants randomised (65:62:65:65)
(mean age (SD) 66 years (9.1); female 66%) follow-up
was 85% at 6 m (n=212). Baseline characteristics and
loss to follow-up were similar between groups. There
were no reported treatment side effects. At 6 m 33%
assigned joint protection were responders compared with
21% with no joint protection (p=0.03). Of those
assigned hand exercises, 28% were responders
compared with 25% with no exercises (n.s.). Differences
in secondary outcomes were not statistically signiﬁcant,
except for improvement in pain self-efﬁcacy with joint
protection (3 m p=0.002; 6 m p=0.001; 12 m p=0.03).
Conclusions These ﬁndings show that occupational
therapists can support self-management in older adults
with hand osteoarthritis, and that joint protection
provides an effective intervention for medium term
outcome. (Funded by the Arthritis Research UK ISRCTN
33870549).
INTRODUCTION
Osteoarthritis (OA) is the commonest form of arth-
ritis in the Western world, and is the leading cause
of disability in older adults, with the hand being one
of the most frequently affected sites.1 In a country
the size of the USA, conservative estimates suggest
that there are 12.4 million people aged 65 years and
over, with OA (33.6%),2 and 2.9 million adults aged
60 years and over with painful, disabling hand OA3
4 which signiﬁcantly restricts daily activities, such as
dressing and bathing, and evidence shows patients
and practitioners perceive that there is little that can
be done.5 6 The majority of people with hand OA
are managed in primary care but often treatments
recommended by guidelines, for example, European
League Against Rheumatism (EULAR) recommen-
dations, are not offered.7
Community-based self-management programmes
have been proposed generally by national bodies in
the USA and Europe as a potential, cost-effective
approach for reducing the impact of OA.8 9 While a
number of authors have reviewed the effectiveness
of self-management programmes for people with
OA,7 10 or evaluated hand OA programmes in sec-
ondary care,11 12 as yet there is limited evidence for
effective management of hand OA in community-
dwelling populations.
Here we report the ﬁndings from the ﬁrst
large-scale randomised trial to investigate the clin-
ical effectiveness of two self-management pro-
grammes for community-dwelling adults aged
50 years and over with hand OA. This multicentre
two-by-two factorial randomised controlled trial
addresses the following questions: Is joint protec-
tion education delivered by an occupational therap-
ist (OT) more effective in reducing hand pain and
disability than no joint protection education in
people with hand OA? Is instruction in hand exer-
cises delivered by an OT more effective in reducing
hand pain and disability than no instruction in
hand exercises in people with hand OA?
METHODS
Design overview
This was a randomised controlled factorial trial.
The main comparisons were between joint protec-
tion and no joint protection, and between hand
exercises and no hand exercises.
The Self Management in OA of the Hand
(SMOotH) trial was conducted from June 2008
through May 2010 at the Arthritis Research UK
Primary Care Centre, Keele University, UK. The
trial was approved by the North West 7 Research
Ethics Committee UK (rec reference: 07/H1008/
235) and was monitored by an Independent Trial
Steering Committee and Data Monitoring
Committee (Trial registration number ISRCTN
33870549). The protocol, including the statistical
analysis plan, has been published previously.13
Setting and participants
Participants aged 50 years and over, registered with
ﬁve general practices in Central Cheshire and
North Staffordshire, UK, were mailed a health
survey between June 2008 and April 2009.
Responders to the health survey were invited for an
assessment at a research clinic to check eligibility
for the trial if they: (1) gave consent to further
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contact; (2) reported hand pain in the last 12 months; (3)
reported hand pain, aching or stiffness on ‘some days’, ‘most
days’ or ‘all days’ in the last month; (4) had an Australian
Canadian Hand OA Outcomes Index (AUSCAN) pain score ≥5
or an AUSCAN function score ≥914 15; (5) reported that they
had not seen an OT or physiotherapist for their hand problem
in the last 6 months; (6) had not had a hand operation, injection
nor injured their hands badly enough to see a doctor in the pre-
vious 6 months and (7) had no other member of their house-
hold participating in the trial. These individuals were mailed a
study information sheet about the trial, and a letter inviting
them to telephone the research centre should they wish to
attend the research clinic.
Those attending the research clinic were assessed for trial eli-
gibility by a research nurse and were included in the trial if
they: gave informed consent to participate in the trial; met the
American College of Rheumatology (ACR) criteria for features
of hand OA,16 17 or had unilateral or bilateral thumb base OA;
did not have an alternative clinical diagnosis, such as inﬂamma-
tory arthritis, and were able to attend for the trial interventions
at participating OT departments. Details of consenting eligible
participants were forwarded to the research centre and partici-
pants were randomised via a remote randomisation service to
one of four groups (see below).
Randomisation and interventions
Randomisation was conducted (with an allocation ratio of
1:1:1:1) by administrative staff at the Keele Musculoskeletal
Clinical Trials Unit, Arthritis Research UK Primary Care Centre,
who had no clinical involvement in the trial. Randomisation
was stratiﬁed by participants’ general practice, and was com-
pleted using random permuted blocks of size 4 (the blocks were
randomly selected using a computer-generated random number
sequence in an ACCESS database). Randomised allocation of
the next patient was concealed from administrative and OT staff
until the point of randomisation. Researchers who entered and
analysed the data were unaware of treatment allocation.
Participants were randomised to one of four ‘cells’: (1) joint
protection; (2) hand exercises; (3) joint protection and hand
exercises combined; (4) no joint protection or hand exercises.
Participants in this last cell received written advice only and did
not receive occupational therapy sessions. Interventions deliv-
ered in all four cells are described in Box 1.
Twelve OTs attended a two-day training programme before
delivering the joint protection education and instruction in hand
exercises (see online supplementary text S1). A pilot study
tested the intervention protocol prior to the commencement of
the main trial.
Outcomes and follow-up
Study outcomes were collected at baseline, 3, 6 and 12 months
post-randomisation by postal questionnaire, and in a clinical
assessment at 6 months. The primary end point for the trial was
at 6-month follow-up. The study was designed so that the
research nurse conducting the 6-month clinical assessment was
blind to treatment allocation. However, if un-blinding did occur
this was recorded.
The primary outcome measure combines the pain and func-
tion subscales of the AUSCAN14 15 and global assessment of
change23 to determine if participants were ‘responders’ to treat-
ment using the OARSI-OMERACT criteria24 (for further details
see footnote to table 1).
Self-reported secondary outcomes included AUSCAN pain,
stiffness and function, global assessment of change in hand
problem, average pain severity over the past 3 days (0–10
numerical rating scale), severity rating of participant-nominated
main functional problem over the past 3 days (0–10 numerical
rating scale), satisfaction with hand function over the past
3 days (0–10 numerical rating scale), health-related quality of
life as measured by the SF12v2,25 and the Arthritis Self Efﬁcacy
pain subscale.26 Additionally, the following secondary outcomes
were measured by a research nurse at baseline and at the
6-month clinical assessment only13: (1) grip strength ( JAMAR);
(2) pinch strength (B & L pinch gauge); (3) functional perform-
ance using the grip ability test (GAT).27
Treatment ﬁdelity
Self-reported performance of hand exercises and use of joint
protection and energy conservation were recorded to assess
level of adherence to the intervention.13 22
Sample size
In this factorial trial, the sample size calculation was based on
the comparison of participants receiving hand exercises (inter-
vention group) and not receiving hand exercises (comparator
group), (the calculation would be identical for the comparison
of joint protection vs no joint protection, as hand exercises and
joint protection were assumed to be independent treatments).28
In participants in the comparator group, 50% would receive
only a leaﬂet and advice, and 50% would receive joint protec-
tion education. Based on ﬁndings from similar populations of
older adults with knee osteoarthritis, we estimated that 25% of
participants receiving leaﬂet and advice only would improve
using the OARSI-OMERACT responder criteria, and 45% of
those receiving joint protection education would improve.24 29
This gave a combined improvement of 35% in participants in
the comparator group, that is, those not receiving hand exer-
cises, assuming equal allocation of participants between treat-
ment groups.
Published information was not available to deﬁne a minimum
clinical important difference for the primary outcome measure.
Therefore, after a consensus discussion with the OTs delivering the
trial interventions, we estimated a worthwhile difference between
groups to be 20%. Hence, the estimate of improvement in the
intervention group which received hand exercises was 55% (ie,
between group differences 35%+20%). To detect a difference of
20% or larger between participants receiving and those not receiv-
ing hand exercises, with 80% power and α of 5%, a total of 212
participants with data at baseline and at 6 months was required. To
allow for a 15% drop-out over the 6-month post-randomisation
period, we planned to recruit 252 participants to the trial, that is,
126 per group for each comparison.
Statistical analysis
The main effectiveness analysis was completed on an intention to
treat (ITT) basis with imputation of missing data (see online sup-
plementary text S2 and S3 for full details of analysis methods).
Continuous outcome measures were analysed using analysis of
covariance (ANCOVA), and binary outcomes by logistic regres-
sion with treatment differences expressed as mean differences or
ORs, as appropriate, with associated 95% CIs. Descriptive statis-
tics were used to describe baseline characteristics of participants
by randomised treatment arm and by loss to follow-up.
Adherence to hand exercises and use of joint protection techni-
ques were analysed by treatment arm at 3, 6 and 12 months.
Sensitivity analyses of the trial results were conducted using
(1) complete-case data and (2) per protocol data at 6 months
using the primary outcome. Analyses were completed in STATA
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Box 1 Interventions delivered to participants
Leaﬂet and advice
All participants were given standardised written information on self-management approaches for hand osteoarthritis (OA) including general
information on looking after hand joints, and using analgesia (reproduced with permission from the Arthritis Research UK leaﬂets ‘Looking
after your joints when you have arthritis’ and ‘Osteoarthritis’, respectively (http://www.arthritisresearchuk.org/), and the National Institute of
Health and Care Excellence (NICE) good practice guidelines.18 Participants were advised to continue with any self-management approaches
they were currently using, and were given advice to consult their general practitioner if symptoms continued to be troublesome.
For 25% of participants this was the sole intervention.
Joint protection, hand exercises
For the remaining 75% of participants, in addition to receiving the leaﬂet, they received one of three interventions: joint protection,
hand exercises, or a combination of the two. The interventions were all delivered over four group sessions (held once a week) by nine
occupational therapists (OTs) in two hospital centres. OTs were rotated every 3 months to minimise the potential for bias. The rotation
order was determined by the OTs availability to deliver the speciﬁc intervention.
Groups included up to six participants, and lasted for a maximum of one hour (1.5 h for the combined intervention). Treatment
session duration and participant attendances were recorded by the OTs on case report forms (CRFs). Attendance adherence was audited
by the study coordinator (SH), and was deﬁned (a priori) to be per protocol if participants attended: session 1, 2, 3 and 4; sessions 1, 2
and 4; sessions 1, 3 and 4; or sessions 1 and 4. Any participant unable to attend week 1 was booked on to the following course.
Joint protection, hand exercises: core components
Both interventions were based on the ‘Looking After Your Joints Programme’ for rheumatoid arthritis (RA),19–22 and included the
following core components:
▸ a general introduction to the programme
▸ education about hand OA and its management
▸ managing pain during everyday activities
▸ how to change habits
▸ long-term and short-term goal setting
▸ weekly individually negotiated home programmes to practise skills taught
▸ weekly review of individually negotiated home programmes
Participants were provided with workbooks (relevant to joint protection, hand exercises, or a combination of the two) including key
points from each meeting, photographs of people with hand OA demonstrating the intervention and weekly activity diaries to complete.
Joint protection principles
In addition to the core components outlined above, this intervention included the following joint protection principles:
▸ distributing the weight of what you lift over several joints (eg, spread the load over two hands)
▸ avoiding putting strain on the thumb and repetitive thumb movements
▸ avoiding prolonged grips in one position
▸ using as large a grip as possible
▸ reducing the effort needed to do a task (eg, use labour-saving gadgets; avoid lifting heavy objects, and reduce the weight of what
you lift)
▸ energy conservation (activity pacing and planning)
Hand exercises
In addition to the core components outlined above, this intervention included the following stretching and strengthening hand and
thumb exercises:
▸ stretching exercises
▸ wrist ﬂexion and extension, pronation and supination
▸ tendon gliding
▸ radial ﬁnger walking
▸ making an ‘O’ with the thumb and index ﬁnger
▸ thumb extension, abduction and opposition to the base of the 5th ﬁnger
Strengthening exercises
▸ using an elastic band to provide resistance to thumb extension, thumb abduction and ﬁnger extension
▸ using Play-Doh rolling and forming into a ring to provide resistance to thumb and ﬁnger extension, squeezing it into a ball, and
pinching off pieces between the thumb and index ﬁngers
▸ holding a 0.5–0.75 kg weight while doing wrist ﬂexion and extension exercises in pronation then supination
The aims of the hand exercise programme were to give the participants a clearer understanding of their hand problem, and to
develop a hand exercise routine to help them improve grip strength and dexterity. Participants were guided to start with three
repetitions of each exercise, gradually building up to 10 repetitions of each exercise daily (or most days), and to perform the exercises
within their limit of discomfort. Exercises could be spread over several exercise sessions during the day and performed more than once a
day. Participants were also asked to write down how many times they aimed to practise the exercises.
Joint protection and hand exercises combined
The individual interventions as described above were combined in the same number of sessions but with an additional half an hour
added to each session.
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12.0.30 No interim analyses were undertaken during the trial or
follow-up period.
Role of the funding source
The trial was funded by the Arthritis Research UK ISRCTN
33870549. The funder played no role in the study.
RESULTS
Study recruitment and follow-up
Trial eligibility, recruitment and follow-up are described in
ﬁgure 1. Overall follow-up rates (including minimum data col-
lection) were: 3 months, 90% (n=232), 6 months, 85%
(n=218), 12 months, 85% (n=219). Rates of loss to follow-up
were similar for each intervention arm (ﬁgure 1) and were not
related to baseline participant characteristics (see online supple-
mentary table S1).
Table 1 shows baseline characteristics of trial participants.
The mean (SD) age of participants was 66 (9.1) years, 66%
were female; the mean (SD) AUSCAN pain and function scores
at trial entry were: pain 9.4 (3.6); function 14.8 (7.6). Overall,
differences in participant characteristics across treatment arms at
baseline were small, however, some between-group differences
were observed for gender, marital status, social class, Body Mass
Index and the presence of thumb OA.
Main trial results
Interaction terms for the primary outcome (see online supple-
mentary table S2) and all other outcomes were not statistically
signiﬁcant (p≥0.05), therefore, treatment effects were evaluated
from the main effects model (ie, joint protection vs no joint pro-
tection; hand exercises vs no hand exercises) after adjustment
for predeﬁned potential confounders.
Table 1 Baseline characteristics of randomised participants
Characteristic
Leaflet and advice
(L and A)
n=65
Joint protection
( JP)
n=62
Hand exercises
(HEx)
n=65
Combined therapy
( JP and HEx)
n=65
All randomised
n=257
Demographic data
Mean (SD): Age (years) 67.2 (9.5) 65.5 (8.6) 64.5 (9.0) 66.0 (9.3) 65.8 (9.1)
Female 40 (62) 43 (69) 41 (63) 46 (71) 170 (66)
Married 44 (69) 43 (71) 36 (55) 42 (65) 165 (65)
Routine or manual occupation*† 34 (52) 24 (39) 32 (49) 31 (48) 121 (47)
Currently working 20 (31) 18 (29) 20 (31) 18 (28) 76 (30)
Mean (SD): Age when left school 15 (1.1) 16 (1.4) 16 (1.2) 15 (1.2) 16 (1.2)
Left school to go to full-time education or university 9 (14) 13 (21) 12 (19) 7 (11) 41 (16)
Gained qualifications through study as an adult 25 (40) 36 (60) 36 (55) 29 (45) 126 (50)
General health and quality of life
Body Mass Index ≥25.0 kg/m2 (overweight/obese)‡ 39 (63) 41 (71) 48 (75) 41 (65) 169 (68)
Mean (SD): SF-12: Physical component (0–100)* 39.7 (12.5) 39.0 (10.4) 41.9 (9.5) 39.9 (10.1) 40.1 (10.7)
Median (IQR): SF-12: Mental component (0–100)* 52.2 (44.0, 58.0) 55.5 (47.7, 60.0) 50.5 (39.9, 57.7) 56.4 (43.0, 60.5) 53.4 (43.3, 59.2)
Clinical characteristics of hand problem
Pain in both hands in last 12 months 60 (92) 52 (84) 57 (88) 56 (88) 225 (88)
Median (IQR): Number of years with hand problem* 5.0 (3.0, 10.0) 4.0 (2.0, 8.0) 5.0 (2.0, 10.0) 5.0 (2.0, 10.0) 5.0 (2.0, 10.0)
Mean (SD): AUSCAN—pain (0–20)* 9.5 (4.0) 10.2 (3.5) 8.8 (3.3) 9.4 (3.7) 9.4 (3.6)
Mean (SD): AUSCAN—stiffness (0–4)* 1.6 (1.0) 1.5 (1.1) 1.4 (1.0) 1.5 (1.1) 1.5 (1.0)
Mean (SD): AUSCAN—function (0–36)* 14.5 (8.0) 15.9 (7.9) 13.8 (7.2) 15.0 (7.3) 14.8 (7.6)
Mean (SD): AUSCAN—total (0–12)* 5.2 (2.2) 5.3 (2.4) 4.7 (1.9) 5.0 (2.3) 5.0 (2.2)
Mean (SD): Arthritis self-efficacy pain subscale (1–10)* 4.8 (1.9) 5.3 (1.7) 5.2 (1.8) 5.1 (1.6) 5.1 (1.8)
Mean (SD): Hand pain severity on average last 3 days
(0–10)*
4.7 (2.2) 5.2 (2.1) 4.3 (1.8) 4.4 (1.9) 4.6 (2.0)
Mean (SD): Severity of main functional problem on
average in the last 3 days (0–10)*
4.9 (2.3) 5.6 (2.5) 4.7 (2.4) 5.0 (2.3) 5.0 (2.4)
Mean (SD): Satisfaction with hand function last 3 days
(0–10)*
4.6 (2.2) 5.4 (2.5) 4.6 (2.4) 4.4 (2.0) 4.8 (2.3)
Median (IQR): Grip strength (lbs)* 35.0 (25.5, 47.5) 31.8 (17.0, 47.5) 31.0 (21.5, 51.0) 33.5 (22.5, 48.5) 33.5 (22.5, 47.5)
Mean (SD): Pinch strength (lbs)* 8.8 (3.3) 8.8 (3.8) 9.0 (3.2) 9.0 (3.3) 8.9 (3.4)
Median (IQR): Grip ability test (seconds)* 32.2 (26.8, 43.6) 30.2 (24.9, 39.7) 32.2 (26.6, 35.8) 32.1 (27.2, 41.5) 32.0 (26.5, 40.4)
ACR criteria met§ 59 (91) 56 (90) 59 (91) 56 (86) 230 (90)
Unilateral or bilateral thumb OA¶ 50 (77) 52 (84) 49 (75) 59 (91) 210 (82)
Figures are numbers and percentages unless otherwise stated. Median (IQR) given for outcome measures with a skewed distribution. Total AUSCAN score calculated as (pain/5)
+stiffness+(function/9).
*Data based on imputed data.
†Based on the ‘lower supervisory/technical’, ‘Semiroutine’ and ‘Routine’ groups of the UK Standard Occupation Classification (2000) for current or most recent paid employment.
‡Body Mass Index grouping defined according to the WHO.
§ACR criteria based on clinical features only (symptom frequency assessed prior to clinical assessment).
¶The eligibility criteria for thumb base OA were determined via examination of the hand joints for features of pain and/or tenderness on palpation and observation/palpation of
deformity. This definition of thumb OA is in keeping with NICE recommendations for diagnosis of OA in UK Primary Care.18
ACR, American College of Rheumatology; AUSCAN, Australian/Canadian Hand Osteoarthritis Index; JP, joint protection; NICE, National Institute of Health and Care Excellence; OA,
osteoarthritis; SF-12, Short Form Health Survey 12 (V.2).
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Figure 1 Recruitment ﬂow diagram for the Smooth trial.
Clinical and epidemiological research
112 Dziedzic K, et al. Ann Rheum Dis 2015;74:108–118. doi:10.1136/annrheumdis-2013-203938
Figure 1 Continued.
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Table 2 shows the number (%) of participants classiﬁed as
‘responders’ according to the OARSI criteria. At our primary end
point (6 months), the proportion of people meeting the OARSI
responder criteria was higher for joint protection (vs no joint pro-
tection) and hand exercises (vs no hand exercises). These differ-
ences reached statistical signiﬁcance for the joint protection
comparison. No statistically signiﬁcant differences were observed
at 3-month and 12-month follow-up for this measure.
Evaluation of the components of the OARSI responder cri-
teria found no signiﬁcant differences in mean AUSCAN pain or
function subscales for either treatment comparison or any
follow-up time point (table 3). The percentage of participants
reporting global improvement was signiﬁcantly higher in the
groups receiving joint protection compared with no joint pro-
tection, and hand exercises versus no hand exercises at 6
months, and also at 3 months and 12 months for the hand exer-
cises comparison only (table 3 and see online supplementary
table S3).
From the remaining secondary outcomes (table 3), arthritis
pain self-efﬁcacy consistently showed statistically signiﬁcant dif-
ferences between those receiving, and those not receiving joint
protection, at all time points, with participants receiving joint
projection showing increased pain self-efﬁcacy.
Treatment ﬁdelity
Those allocated to hand exercises performed a structured exer-
cise programme more often than those who were not (see
online supplementary table S4). On average, participants allo-
cated to joint protection used joint protection and energy con-
servation techniques more frequently than those who were not
(see online supplementary table S4).
Sensitivity analyses
Overall, these ﬁndings were largely replicated in a complete case
analysis with no imputation of missing data (see online supple-
mentary table S5). A per-protocol analysis of the OARSI
responder criteria at 6-month follow-up replicated results from
the ITT analysis, although statistical signiﬁcance of the joint pro-
tection comparison was marginal (p=0.07) (see online supple-
mentary table S6).
Adverse events
No adverse events were reported as a result of the interventions.
DISCUSSION
In this multicentre randomised controlled factorial trial, we
evaluated whether joint protection education delivered by OTs
was more effective in reducing hand pain and disability than no
joint protection in community-dwelling older adults with hand
OA. At 6 months, the primary end point, participants who
received the joint protection intervention were statistically sig-
niﬁcantly more likely to be classiﬁed as responders to treatment
than those not receiving joint protection (33% cf 21%). This
was not maintained over 12 months. We also evaluated whether
Figure 1 Continued.
Table 2 Treatment effectiveness evaluated for the OARSI responder criteria
Outcome measure
3 months 6 months 12 months
No JP* JP No HEx* HEx No JP* JP No HEx* HEx No JP* JP No HEx* HEx
n 130 127 127 130 130 127 127 130 130 127 127 130
‘Responders’ (OARSI)†, n (%) 22 (17) 28 (22) 24 (19) 26 (20) 27 (21) 42 (33) 32 (25) 36 (28) 27 (21) 34 (27) 24 (19) 38 (29)
Adjusted‡ OR(95% CI) 1.35 (0.68 to 2.68) 0.99 (0.50 to 1.95) 2.10 (1.09 to 4.04) 1.14 (0.59 to 2.20) 1.57 (0.83 to 3.00) 1.76 (0.93 to 3.34)
*Reference category.
†Participants met the OARSI responder criteria if (a) relative change in AUSCAN pain or function was ≥50% and absolute change was ≥20 or (b) at least two of the following applied:
relative change in pain ≥20% and absolute change ≥10, relative change in function ≥20% and absolute change ≥10 or participants reported they were better, much better, or
completely recovered on the global assessment of change question. Absolute change (baseline—follow-up score) and relative change (absolute change/baseline score) were calculated
after AUSCAN measures were scaled from 1 to 101 to avoid dividing by 0 when calculating relative change.24 Responses in the ‘better’, ‘much better’ or ‘completely recovered’
categories on the global assessment of change question were defined as ‘improvement’.
‡Adjusted for age, gender, social class, General Practitioner (GP) practice and length of time with a hand condition and the other main effect of interest.
AUSCAN, Australian Canadian Hand Osteoarthritis Index; HEx, hand exercise; JP, joint protection; OA, Osteoarthritis.
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Table 3 Treatment effectiveness for secondary outcome measures by main treatment effects
Outcome measure
3 months 6 months 12 months
No JP* JP No HEx* HEx No JP* JP No HEx* HEx No JP* JP No HEx* HEx
n 130 127 127 130 130 127 127 130 130 127 127 130
Global assessment of change (%)
n (%) Improved† 39 (30) 43 (34) 29 (23) 53 (41) 30 (23) 52 (41) 28 (22) 55 (42) 34 (26) 46 (36) 28 (22) 51 (39)
Adjusted OR(95% CI) 1.23 (0.67 to 2.25) 2.48 (1.33 to 4.60) 2.71 (1.39 to 5.25) 2.79 (1.44 to 5.40) 1.82 (0.96 to 3.45) 2.22 (1.20 to 4.11)
AUSCAN pain (0–20)
Mean (SD) 9.0 (3.5) 9.3 (3.0) 9.5 (3.4) 8.8 (3.1) 9.4 (4.0) 9.0 (3.9) 9.4 (4.0) 9.0 (3.9) 9.4 (3.9) 9.6 (3.8) 9.9 (3.7) 9.1 (3.9)
Adjusted mean difference (95% CI) 0.01 (−0.71 to 0.74) −0.31 (−1.03 to 0.42) −0.79 (−1.70 to 0.12) 0.06 (−0.85 to 0.97) −0.09 (−0.99 to 0.81) −0.35 (−1.27 to 0.56)
AUSCAN stiffness (0–4)
Mean (SD) 1.5 (1.0) 1.5 (1.0) 1.6 (1.0) 1.4 (1.0) 1.6 (1.0) 1.4 (1.0) 1.5 (1.0) 1.5 (1.0) 1.6 (1.0) 1.5 (1.0) 1.7 (0.9) 1.5 (1.0)
Adjusted mean difference (95% CI) 0.02 (−0.19 to 0.22) −0.13 (−0.33 to 0.07) −0.21 (−0.43 to 0.02) 0.11 (−0.11 to 0.33) −0.05 (−0.27 to 0.17) −0.14 (−0.36 to 0.08)
AUSCAN function (0–36)
Mean (SD) 15.1 (7.7) 15.3 (6.9) 15.9 (7.7) 14.5 (6.8) 14.4 (7.9) 14.9 (7.5) 15.3 (7.7) 14.1 (7.7) 15.1 (7.9) 16.3 (7.5) 16.3 (7.6) 15.1 (7.8)
Adjusted mean difference (95% CI) −0.61 (−1.96 to 0.74) −0.70 (−2.03 to 0.62) −0.36 (−1.85 to 1.14) −0.51 (−2.04 to 1.02) 0.51 (−1.08 to 2.10) −0.60 (−2.18 to 0.98)
AUSCAN total (0–12)
Mean (SD) 5.0 (2.2) 5.0 (1.9) 5.3 (2.1) 4.7 (1.9) 5.1 (2.3) 4.8 (2.3) 5.1 (2.4) 4.9 (2.3) 5.2 (2.2) 5.3 (2.3) 5.5 (2.2) 5.0 (2.3)
Adjusted mean difference (95% CI) −0.06 (−0.45 to 0.33) −0.25 (−0.64 to 0.14) −0.43 (−0.91 to 0.06) 0.09 (−0.39 to 0.57) −0.03 (−0.51 to 0.46) −0.26 (−0.74 to 0.22)
Arthritis self-efficacy for pain (1–10)
Mean (SD) 5.5 (1.9) 6.3 (1.8) 5.8 (2.0) 6.0 (1.7) 5.7 (1.9) 6.5 (1.7) 6.0 (1.8) 6.1 (1.8) 5.4 (2.0) 6.0 (1.8) 5.5 (1.9) 5.8 (2.0)
Adjusted mean difference (95% CI) 0.66 (0.24 to 1.08) 0.16 (−0.25 to 0.58) 0.74 (0.30 to 1.19) 0.09 (−0.37 to 0.55) 0.54 (0.07 to 1.02) 0.16 (−0.33 to 0.65)
Hand pain severity last 3 days (0–10)
Mean (SD) 4.4 (2.2) 4.3 (1.9) 4.6 (2.1) 4.1 (2.0) 4.1 (2.2) 4.4 (2.1) 4.1 (2.1) 4.4 (2.2) 4.5 (2.2) 4.6 (2.3) 4.8 (2.2) 4.3 (2.3)
Adjusted mean difference (95% CI) −0.29 (−0.75 to 0.17) −0.09 (−0.56 to 0.38) 0.06 (−0.46 to 0.58) 0.53 (0.01 to 1.05) 0.03 (−0.53 to 0.59) −0.28 (−0.84 to 0.27)
Severity of worse problem in the last 3 days (0–10)
Mean (SD) 4.7 (2.3) 4.7 (2.2) 5.0 (2.3) 4.5 (2.2) 4.8 (2.4) 4.7 (2.6) 4.9 (2.5) 4.7 (2.4) 4.9 (2.2) 4.8 (2.4) 5.2 (2.2) 4.5 (2.3)
Adjusted mean difference (95% CI) −0.23 (−0.75 to 0.30) −0.27 (−0.78 to 0.24) −0.42 (−1.07 to 0.24) −0.01 (−0.65 to 0.62) −0.33 (−0.90 to 0.23) −0.49 (−1.08 to 0.10)
Satisfaction with hand function in the last 3 days (0–10)
Mean (SD) 4.8 (2.3) 4.4 (2.2) 4.9 (2.3) 4.3 (2.1) 4.5 (2.4) 4.1 (2.4) 4.2 (2.5) 4.4 (2.4) 4.9 (2.2) 4.8 (2.4) 5.2 (2.2) 4.5 (2.3)
Adjusted mean difference (95% CI) −0.45 (−0.98 to 0.08) −0.43 (−0.96 to 0.11) −0.57 (−1.15 to 0.01) 0.37 (−0.22 to 0.95) −0.19 (−0.75 to 0.38) −0.46 (−1.06 to 0.14)
Grip strength (lbs)
Mean (SD) N/A N/A N/A N/A 43.2 (22.8) 41.0 (20.8) 41.3 (21.7) 43.0 (22.0) N/A N/A N/A N/A
Adjusted mean difference (95% CI) N/A N/A −1.04 (−4.16 to 2.07) 1.17 (−2.13 to 4.46) N/A N/A
Pinch strength (lbs)
Mean (SD) N/A N/A N/A N/A 9.2 (3.5) 8.8 (3.6) 8.8 (3.4) 9.2 (3.7) N/A N/A N/A N/A
Adjusted mean difference (95% CI) N/A N/A −0.27 (−0.88 to 0.34) 0.33 (−0.29 to 0.95) N/A N/A
Grip ability test (seconds)
Mean (SD) N/A N/A N/A N/A 33.9 (19.2) 31.3 (10.8) 34.5 (19.4) 30.8 (10.6) N/A N/A N/A N/A
Adjusted mean difference (95% CI) N/A N/A −1.96 (−5.67 to 1.76) −2.06 (−5.73 to 1.60) N/A N/A
Continued
C
linical
and
epidem
iological
research
Dziedzic
K,etal.Ann
Rheum
Dis
2015;74:108
–118.doi:10.1136/annrheum
dis-2013-203938
115
instruction in hand exercises was more effective in reducing
hand pain and disability than no instruction in hand exercises,
and found there was no statistically signiﬁcant difference in the
number of ‘responders’ between those receiving and not receiv-
ing hand exercises. Participants receiving joint protection educa-
tion reported improved pain self-efﬁcacy at 3- , 6- and 12-
months.
The research question arose from clinical practice and was
shaped by OT and patient and public involvement.13 We fol-
lowed the OMERACT-OARSI recommendations for design and
conduct of clinical trials of OA.16 Our trial, therefore, had
good internal validity with adequate sample size, high
follow-up rates and strategies to minimise potential therapist
effect. However, because we selected volunteers who indicated
that they were able and willing to participate in an OT pro-
gramme, the results may not be generalisable to all older adults
with hand OA.
All participants received the same advice and leaﬂet from the
research nurse on entry into the trial prior to randomisation,
and there were no differences between groups in the timing of
this. Additional intervention was delivered using the same
protocol for timing of treatment appointments for each arm (no
additional treatment; joint protection; hand exercises; joint pro-
tection and hand exercises) and appointments for classes were
monitored. Beneﬁt of classes may have been diluted at 3 months
as some participants failed to attend the ﬁrst set of classes avail-
able so were still completing classes after the 3-month
follow-up.
Reviews of non-surgical treatments for hand OA31–33 and
international guidelines7 8 have identiﬁed a gap in evidence for
the effectiveness of non-pharmacological approaches in the
management of hand OA in community-dwelling older adults.
Guidelines acknowledge that the strength of the evidence under-
pinning recommendations for self-management is weak. They
highlight one RCT12 comparing a joint protection programme
plus home-based hand exercise (range of motion) versus infor-
mation alone in 40 patients with hand OA. Stamm’s study,
while small, has been instrumental in informing clinical guide-
lines for hand OA.7 8 More recently, Stukstette et al11 investi-
gated the effectiveness of an intensive group-based
multidisciplinary treatment programme incorporating self-
management, ergonomic principles and exercises. The ﬁndings
of this study in participants recruited from rheumatology clinics
suggest that such a programme is not effective in the short term.
Our study has added to this evidence by investigating the inde-
pendent effects of each intervention and demonstrating the effect-
iveness of joint protection in hand OA. All exercises were
supervised in the classes by OTs experienced in treating hand OA,
however, as we did not measure biomechanical outcome, we
cannot determine whether our exercise programme had any effect
(positive or negative) on joint deformities. Adherence to home
exercises was good—those allocated to hand exercises performed
a structured exercise programme more often than those who were
not—but gains in grip strength and other performance measures
were not shown to be statistically signiﬁcant, contrary to ﬁndings
of others.32 Adherence to joint protection approaches was also
good, and it is possible that once joint protection principles are
established, they may be easier to sustain in the shorter term, but
the beneﬁts tailor off in the longer term.
Although the magnitude of beneﬁt for joint protection was
lower than our prespeciﬁed minimally clinically important dif-
ference, it still reached statistical signiﬁcance due to the add-
itional power available in our study from an overestimation of
the percentage of participants meeting the OARSI responder
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criteria in the sample size calculation. Our study, therefore, adds
to the evidence for expected differences between interventions
and comparators for non-pharmacological studies in commu-
nity-dwelling populations, 50 years and older, with hand OA.
In clinical practice, only those patients who seek help are
treated and only a small subgroup of the population with disab-
ling hand pain in community-dwelling populations, aged
50 years and older, see an OT (3% in a 12-month period).6 Our
eligible study population was deﬁned using criteria recom-
mended in secondary care settings,16 and the treatment
approaches should, therefore, be generalisable to patients who
are referred to OT. Our ﬁndings also highlight the feasibility of
supporting self-management in community settings and offer
strategies to close the gap between what patients should
receive7–9 and what therapies are offered.6
While hand OA is common, and has a signiﬁcant impact and
associated disability,34 consultations with a General Practitioner
(GP) are low.6 People with hand problems consider the diagnosis of
‘hand OA’ to represent a serious condition, but they often perceive
that nothing can be done.5 Our study population was recruited via
the community using the ACR criteria for hand OA, hence, to have
achieved any improvement in this group is important.
Joint pain in older adults and OA are public health problems
that challenge our healthcare professionals and healthcare delivery
systems. We have produced clear evidence about the most clinically
effective methods of delivering and supporting self-management
at 6 months for older adults with hand OA to justify and inform
guidelines and recommendations. We have shown that support for
self-management, through a joint protection education pro-
gramme delivered by OTs, provides an effective approach for
community-dwelling older adults with hand OA.
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